Reply to D. Pouessel et al, J.B. Aragon-Ching, and B.A. Adesunloye

Elizabeth R. Plimack; Jean Hoffman-Censits; Jonathan E. Rosenberg; Yu Ning Wong; Joaquim Bellmunt; Toni K. Choueiri

doi:10.1200/JCO.2014.58.5281

Reply to D. Pouessel et al, J.B. Aragon-Ching, and B.A. Adesunloye

Elizabeth R. Plimack
, Jean Hoffman-Censits
, Jonathan E. Rosenberg
, Yu Ning Wong
, Joaquim Bellmunt
, Toni K. Choueiri

Thomas Jefferson University
Memorial Sloan-Kettering Cancer Center
Fox Chase Cancer Center
Dana-Farber Cancer Institute

Research output: Contribution to journal › Letter › peer-review

Original language	English
Article number	A27
Pages (from-to)	4171-4172
Number of pages	2
Journal	Journal of Clinical Oncology
Volume	32
Issue number	36
DOIs	https://doi.org/10.1200/JCO.2014.58.5281
State	Published - Jan 1 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Antineoplastic Combined Chemotherapy Protocols/therapeutic use
Biomarkers, Tumor/analysis
Carcinoma, Transitional Cell/chemistry
Cystectomy
Female
Granulocyte Colony-Stimulating Factor/therapeutic use
Humans
Male
Neoadjuvant Therapy/methods
Protective Agents/therapeutic use
Urinary Bladder Neoplasms/chemistry

Access to Document

10.1200/JCO.2014.58.5281

Cite this

@article{53f629ba99174bc38faa9937fbd92465,

title = "Reply to D. Pouessel et al, J.B. Aragon-Ching, and B.A. Adesunloye",

keywords = "Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Biomarkers, Tumor/analysis, Carcinoma, Transitional Cell/chemistry, Cystectomy, Female, Granulocyte Colony-Stimulating Factor/therapeutic use, Humans, Male, Neoadjuvant Therapy/methods, Protective Agents/therapeutic use, Urinary Bladder Neoplasms/chemistry",

author = "Plimack, \{Elizabeth R.\} and Jean Hoffman-Censits and Rosenberg, \{Jonathan E.\} and Wong, \{Yu Ning\} and Joaquim Bellmunt and Choueiri, \{Toni K.\}",

year = "2014",

month = jan,

day = "1",

doi = "10.1200/JCO.2014.58.5281",

language = "English",

volume = "32",

pages = "4171--4172",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams and Wilkins",

number = "36",

}

TY - JOUR

T1 - Reply to D. Pouessel et al, J.B. Aragon-Ching, and B.A. Adesunloye

AU - Plimack, Elizabeth R.

AU - Hoffman-Censits, Jean

AU - Rosenberg, Jonathan E.

AU - Wong, Yu Ning

AU - Bellmunt, Joaquim

AU - Choueiri, Toni K.

PY - 2014/1/1

Y1 - 2014/1/1

KW - Antineoplastic Combined Chemotherapy Protocols/therapeutic use

KW - Biomarkers, Tumor/analysis

KW - Carcinoma, Transitional Cell/chemistry

KW - Cystectomy

KW - Female

KW - Granulocyte Colony-Stimulating Factor/therapeutic use

KW - Humans

KW - Male

KW - Neoadjuvant Therapy/methods

KW - Protective Agents/therapeutic use

KW - Urinary Bladder Neoplasms/chemistry

UR - https://www.scopus.com/pages/publications/84919752984

U2 - 10.1200/JCO.2014.58.5281

DO - 10.1200/JCO.2014.58.5281

M3 - Letter

C2 - 25385730

SN - 0732-183X

VL - 32

SP - 4171

EP - 4172

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 36

M1 - A27

ER -

Reply to D. Pouessel et al, J.B. Aragon-Ching, and B.A. Adesunloye

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this